Alkermes
ALKS
#3169
Rank
S$6.07 B
Marketcap
S$36.80
Share price
-2.30%
Change (1 day)
-10.52%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): S$0.53 Billion

According to Alkermes's latest financial reports the company's current earnings are S$1.52 Billion. In 2024 the company made an earning of S$0.60 Billion a decrease over its 2023 earnings that were of S$0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.53 B-11.21%
2024 S$0.60 B-17.97%
2023 S$0.73 B-468.52%
2022 -S$0.2 Billion449.24%
2021 -S$36.28 Million-68.04%
2020 -S$0.12 Billion-52.1%
2019 -S$0.24 Billion64.49%
2018 -S$0.15 Billion-15.04%
2017 -S$0.17 Billion-34.2%
2016 -S$0.26 Billion-5.34%
2015 -S$0.28 Billion35084.97%
2014 -S$0.78 Million
2012 S$9.58 M-117.81%
2011 -S$53.83 Million-12.69%
2010 -S$61.66 Million94.3%
2009 -S$31.73 Million-117.7%
2008 S$0.17 B622.63%
2007 S$24.8 M
2004 -S$98.11 Million-14.48%
2003 -S$0.12 Billion11.88%
2002 -S$0.11 Billion39.65%
2001 -S$73.43 Million5.73%
2000 -S$69.45 Million-28.91%
1999 -S$97.69 Million237.28%
1998 -S$28.97 Million100.05%
1997 -S$14.48 Million-37.93%
1996 -S$23.33 Million82.72%
1995 -S$12.77 Million-26.79%
1994 -S$17.44 Million-72.78%
1993 -S$64.06 Million208.07%
1992 -S$20.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Acorda Therapeutics
ACOR
-S$0.36 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.37 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.83 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.30 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.90 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$2.28 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
-S$0.28 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.75 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
S$21.20 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland